Arjo is a global provider of devices, systems and services that improve the quality of life of people with reduced mobility and solve health problems related to age. We create value by improving the clinical status of patients and the working conditions of health professionals. In this way, we contribute to the creation of a balanced health care system - always with people in mind.
Our main clients are private and public health care units that deal with intensive and long-term care. Our offer includes products and solutions for the transport and transfer of patients, performing hygiene and disinfection operations, for prophylaxis and diagnostics of venous thromboembolism, as well as medical beds and therapeutic areas. We also offer training in the use of products offered by us.
Our product range includes medical equipment and integrated solutions in the field of patient transport and hygiene, prevention of pressure sores, prophylaxis of venous thromboembolism, disinfection and a wide range of medical beds.
32.50.Z - Production of medical devices, instruments, and products, including dental products
26.60.Z - Manufacture of irradiation equipment, electromedical and electrotherapeutic equipment
27.9 - Manufacture of other electrical equipment
28 - Manufacture of machines and equipment not elsewhere classified
31 - Manufacture of furniture
32.99.Z - Production of other products not classified elsewhere
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.90.Z - Non-specialized wholesale trade
47.74.Z - Retail sale of medical and orthopedic products
77.3 - Rental and leasing of other machinery, equipment, and tangible assets
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 13,5 | 44,7 | 36,3 | -18,7 |
EBITDA | 20,9 | 50,9 | 45,6 | -10,4 |
Short time liabilities | 60,2 | 74,3 | 139,7 | 88 |
Equity capital | 135,5 | 148 | 157,5 | 6,4 |
Operating profit (EBIT) | 15,4 | 45,8 | 39,7 | -13,2 |
Assets | 200,6 | 227,9 | 300,6 | 31,9 |
Net profit (loss) | 8,6 | 37,3 | 29,5 | -21 |
Cash | 31,1 | 16,3 | 37,1 | 127 |
Net income from sale | 485,2 | 518,8 | 579,9 | 11,8 |
Liabilities and provisions for liabilities | 65,1 | 80 | 143,2 | 79 |
Working assets | 160,5 | 175,5 | 245,1 | 39,6 |
Depreciation | 5,5 | 5,1 | 5,9 | 15,1 |
% | % | % | p.p. | |
Profitability of capital | 6,4 | 25,2 | 18,7 | -6,5 |
Equity capital to total assets | 67,6 | 64,9 | 52,4 | -12,5 |
Gross profit margin | 2,8 | 8,6 | 6,3 | -2,3 |
EBITDA Margin | 4,3 | 9,8 | 7,9 | -1,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 45 | 52 | 88 | 36 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane